GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Beijing Airdoc Technology Co Ltd (HKSE:02251) » Definitions » EBIT

Beijing Airdoc Technology Co (HKSE:02251) EBIT : HK$-158.9 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Beijing Airdoc Technology Co EBIT?

Beijing Airdoc Technology Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was HK$-114.9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-158.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Beijing Airdoc Technology Co's annualized ROC % for the quarter that ended in Dec. 2023 was -36.39%. Beijing Airdoc Technology Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -218.41%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Beijing Airdoc Technology Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -46.33%.


Beijing Airdoc Technology Co EBIT Historical Data

The historical data trend for Beijing Airdoc Technology Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Airdoc Technology Co EBIT Chart

Beijing Airdoc Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
-96.91 -93.92 -174.16 -203.58 -158.94

Beijing Airdoc Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only -128.79 -116.62 -92.47 -44.03 -114.91

Competitive Comparison of Beijing Airdoc Technology Co's EBIT

For the Health Information Services subindustry, Beijing Airdoc Technology Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Airdoc Technology Co's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Beijing Airdoc Technology Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Beijing Airdoc Technology Co's EV-to-EBIT falls into.



Beijing Airdoc Technology Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-158.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Airdoc Technology Co  (HKSE:02251) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Beijing Airdoc Technology Co's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-206.948 * ( 1 - 0.66% )/( (532.084 + 597.86)/ 2 )
=-205.5821432/564.972
=-36.39 %

where

Invested Capital(Q: Jun. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1939.808 - 44.868 - ( 1362.856 - max(0, 98.727 - 1540.941+1362.856))
=532.084

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1842.921 - 47.225 - ( 1197.836 - max(0, 120.575 - 1402.145+1197.836))
=597.86

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Beijing Airdoc Technology Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-229.824/( ( (32.606 + max(58.051, 0)) + (31.113 + max(88.686, 0)) )/ 2 )
=-229.824/( ( 90.657 + 119.799 )/ 2 )
=-229.824/105.228
=-218.41 %

where Working Capital is:

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(88.344 + 59.69 + 0) - (44.868 + 0 + 45.115)
=58.051

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(87.109 + 43.898 + 68.823) - (47.225 + 0 + 63.919)
=88.686

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Beijing Airdoc Technology Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=-158.941/343.038
=-46.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Airdoc Technology Co EBIT Related Terms

Thank you for viewing the detailed overview of Beijing Airdoc Technology Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Airdoc Technology Co (HKSE:02251) Business Description

Traded in Other Exchanges
N/A
Address
West Third Ring North Road, Room 21, 4th Floor, Building 2, A2 Yard, Haidian District, Beijing, CHN
Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices and other services.
Executives
Mialkos Tomasz Jakub 2101 Beneficial owner
Zhang Dalei 2501 Other
Fosun Holdings Limited 2201 Interest of corporation controlled by you
Yadong Beichen Venture Investment Co., Ltd. 2101 Beneficial owner
Shanghai Ruikun Venture Capital Investment Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Fosun Industrial Investment Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd. 2201 Interest of corporation controlled by you
Guo Guangchang 2201 Interest of corporation controlled by you
Fosun International Limited 2201 Interest of corporation controlled by you
Fosun International Holdings Ltd. 2201 Interest of corporation controlled by you
Chen Mingqiang 2501 Other
Gao Fei 2501 Other
Niagara Falls Holding Limited 2101 Beneficial owner
China Life Franklin Asset Management Co., Limited
China Life Insurance (group) Company

Beijing Airdoc Technology Co (HKSE:02251) Headlines

No Headlines